BET Protein Inhibitor Apabetalone Suppresses Inflammatory Hyperactivation of Monocytes From Patients With Cardiovascular Disease and Type 2 Diabetes

被引：0
|
作者：
Wasiak, Sylwia
Dzobo, Kim
Rakai, Brooke
Kaiser, Yannick
Versloot, Miranda
Bahjat, Mahnoush
Stotz, Stephanie
Fu, Li
Sweeney, Michael
Johansson, Jan
Wong, Norman
Stroes, Erik
Kroon, Jeffrey
Kulikowski, Ewelina
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
10.1161/circ.142.suppl_3.14127
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14127
引用
收藏
页数：2
相关论文
共 50 条
  • [1] BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes
    Sylwia Wasiak
    Kim E. Dzobo
    Brooke D. Rakai
    Yannick Kaiser
    Miranda Versloot
    Mahnoush Bahjat
    Stephanie C. Stotz
    Li Fu
    Michael Sweeney
    Jan O. Johansson
    Norman C. W. Wong
    Erik S. G. Stroes
    Jeffrey Kroon
    Ewelina Kulikowski
    [J]. Clinical Epigenetics, 2020, 12
  • [2] BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes
    Wasiak, Sylwia
    Dzobo, Kim E.
    Rakai, Brooke D.
    Kaiser, Yannick
    Versloot, Miranda
    Bahjat, Mahnoush
    Stotz, Stephanie C.
    Fu, Li
    Sweeney, Michael
    Johansson, Jan O.
    Wong, Norman C. W.
    Stroes, Erik S. G.
    Kroon, Jeffrey
    Kulikowski, Ewelina
    [J]. CLINICAL EPIGENETICS, 2020, 12 (01)
  • [3] Apabetalone - BET protein inhibition in cardiovascular disease and Type 2 diabetes
    Brandts, Julia
    Ray, Kausik K.
    [J]. FUTURE CARDIOLOGY, 2020, 16 (05) : 385 - 395
  • [4] EPIGENETIC READER INHIBITOR APABETALONE (RVX-208) COUNTERS PROINFLAMMATORY HYPERACTIVATION OF CD14+MONOCYTES FROM PATIENTS WITH TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE
    Wasiak, Sylwia
    Dzobo, Kim E.
    Bahjat, Mahnoush
    Rakai, Brooke D.
    Kaiser, Yannick
    Versloot, Miranda
    Kroon, Jeffrey
    Stotz, Stephanie C.
    Tsujikawa, Laura M.
    Fu, Li
    Gilham, Dean
    Sarsons, Christopher D.
    Sweeney, Michael
    Johansson, Jan O.
    Wong, Norman C. W.
    Stroes, Erik S. G.
    Kulikowski, Ewelina
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 2217 - 2217
  • [5] Epigenetic Reader Inhibitor Apabetalone (RVX-208) Counters Proinflammatory Hyperactivation of Cd14+Monocytes From Patients With Type 2 Diabetes and Cardiovascular Disease
    Wasiak, Sylwia
    Dzobo, Kim E.
    Bahjat, Mahnoush
    Rakai, Brooke D.
    Kaiser, Yannick
    Versloot, Miranda
    Kroon, Jeffrey
    Stotz, Stephanie C.
    Tsujikawa, Laura M.
    Fu, Li
    Gilham, Dean
    Sarsons, Christopher D.
    Sweeney, Michael
    Johansson, Jan O.
    Wong, Norman C.
    Stroes, Erik S.
    Kulikowski, Ewelina
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40
  • [6] Apabetalone, a selective BET protein inhibitor, reduces ischemic cardiovascular events and hospitalization for heart failure in patients with acute coronary syndrome and type 2 diabetes
    Ray, K. K.
    Nicholls, S. J.
    Buhr, K. A.
    Ginsberg, H. N.
    Kalantar-Zadeh, K.
    Johansson, J. O.
    Kulikowski, E.
    Toth, P. P.
    Wong, N.
    Sweeney, M.
    Schwartz, G. G.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 1425 - 1425
  • [7] APABETALONE (RVX-208) ATTENUATES INFLAMMATORY MILIEU UNDERLYING ADHESION OF MONOCYTES TO ENDOTHELIAL CELLS IN TYPE 2 DIABETES MELLITUS WITH CARDIOVASCULAR DISEASE PATIENTS
    Tsujikawa, L.
    Kulikowski, E.
    Rakai, B.
    Fu, L.
    Das, S.
    Halliday, C.
    Sarsons, C.
    Daze, E.
    Wasiak, S.
    Gilham, D.
    Johansson, J.
    Sweeney, M.
    Wong, N. C. W.
    [J]. ATHEROSCLEROSIS, 2019, 287 : E252 - E252
  • [8] Apabetalone (RVX-208) Attenuates an Inflammatory Milieu that Enhances Adhesion of Monocytes to Endothelial Cells in Type 2 Diabetes Mellitus with Cardiovascular Disease Patients
    Tsujikawa, Laura
    Kulikowski, Ewelina
    Calosing, Cyrus
    Wasiak, Sylwia
    Gilham, Dean
    Halliday, Christopher
    Johansson, Jan O.
    Sweeney, Michael
    Wong, Norman C.
    [J]. DIABETES, 2019, 68
  • [9] Downregulation of the Complement Cascade In Vitro, in Mice and in Patients with Cardiovascular Disease by the BET Protein Inhibitor Apabetalone (RVX-208)
    Wasiak, Sylwia
    Gilham, Dean
    Tsujikawa, Laura M.
    Halliday, Christopher
    Calosing, Cyrus
    Jahagirdar, Ravi
    Johansson, Jan
    Sweeney, Michael
    Wong, Norman C.
    Kulikowski, Ewelina
    [J]. JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2017, 10 (04) : 337 - 347
  • [10] Downregulation of the Complement Cascade In Vitro, in Mice and in Patients with Cardiovascular Disease by the BET Protein Inhibitor Apabetalone (RVX-208)
    Sylwia Wasiak
    Dean Gilham
    Laura M. Tsujikawa
    Christopher Halliday
    Cyrus Calosing
    Ravi Jahagirdar
    Jan Johansson
    Michael Sweeney
    Norman C. Wong
    Ewelina Kulikowski
    [J]. Journal of Cardiovascular Translational Research, 2017, 10 : 337 - 347
12345